PL374186A1 - Środek leczniczy o przedłużonym uwalnianiu substancji czynnej, zawierający 1-dimetyloamino-3-(3-metoksyfenylo)-2-metylopentan-3-ol - Google Patents

Środek leczniczy o przedłużonym uwalnianiu substancji czynnej, zawierający 1-dimetyloamino-3-(3-metoksyfenylo)-2-metylopentan-3-ol

Info

Publication number: PL374186A1
Authority: PL; Poland
Prior art keywords: pentan; dimethylamino; medicament; methoxy; phenyl
Prior art date: 2002-05-29

Application number

PL03374186A

Other languages

English (en)

Other versions

PL218397B1 (pl

Inventor

Johannes Bartholomäuse

Iris Ziegler

Original Assignee

Grünenthal GmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-05-29

Filing date

2003-05-26

Publication date

2005-10-03

2003-05-26 Application filed by Grünenthal GmbH filed Critical Grünenthal GmbH

2005-10-03 Publication of PL374186A1 publication Critical patent/PL374186A1/pl

2014-11-28 Publication of PL218397B1 publication Critical patent/PL218397B1/pl

Links

PZNRRUTVGXCKFC-UHFFFAOYSA-N 1-(dimethylamino)-3-(3-methoxyphenyl)-2-methylpentan-3-ol Chemical compound CN(C)CC(C)C(O)(CC)C1=CC=CC(OC)=C1 PZNRRUTVGXCKFC-UHFFFAOYSA-N 0.000 title 1
239000013543 active substance Substances 0.000 title 1
230000003111 delayed effect Effects 0.000 title 1
239000003814 drug Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Rheumatology (AREA)
Urology & Nephrology (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL374186A 2002-05-29 2003-05-26 Preparat farmaceutyczny o przedłużonym uwalnianiu, który w matrycy o przedłużonym uwalnianiu substancji czynnej, zawiera 1-dimetyloamino-3- (3-metoksyfenylo)-2- metylopentan-3-ol, oraz jego zastosowanie PL218397B1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE10224108A DE10224108A1 (de)	2002-05-29	2002-05-29	1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol enthaltendes Arzneimiitel mit verzögerter Wirkstofffreisetzung

Publications (2)

Publication Number	Publication Date
PL374186A1 true PL374186A1 (pl)	2005-10-03
PL218397B1 PL218397B1 (pl)	2014-11-28

Family

ID=29557413

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL374186A PL218397B1 (pl)	2002-05-29	2003-05-26	Preparat farmaceutyczny o przedłużonym uwalnianiu, który w matrycy o przedłużonym uwalnianiu substancji czynnej, zawiera 1-dimetyloamino-3- (3-metoksyfenylo)-2- metylopentan-3-ol, oraz jego zastosowanie

Country Status (14)

Country	Link
EP (1)	EP1507519B1 (pl)
JP (1)	JP5459818B2 (pl)
AR (1)	AR039900A1 (pl)
AT (1)	ATE326218T1 (pl)
AU (1)	AU2003238397A1 (pl)
CA (1)	CA2488220C (pl)
DE (2)	DE10224108A1 (pl)
DK (1)	DK1507519T3 (pl)
ES (1)	ES2263976T3 (pl)
MY (1)	MY134311A (pl)
PE (1)	PE20040529A1 (pl)
PL (1)	PL218397B1 (pl)
PT (1)	PT1507519E (pl)
WO (1)	WO2003099267A1 (pl)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4389393A (en) *	1982-03-26	1983-06-21	Forest Laboratories, Inc.	Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US5032406A (en) *	1989-02-21	1991-07-16	Norwich Eaton Pharmaceuticals, Inc.	Dual-action tablet
US5582837A (en) *	1992-03-25	1996-12-10	Depomed, Inc.	Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
JPH06172161A (ja) *	1992-12-10	1994-06-21	Shin Etsu Chem Co Ltd	徐放性錠剤
DE4329794C2 (de) *	1993-09-03	1997-09-18	Gruenenthal Gmbh	Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung
DE4426245A1 (de) *	1994-07-23	1996-02-22	Gruenenthal Gmbh	1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
JPH1017497A (ja) *	1996-07-02	1998-01-20	Takeda Chem Ind Ltd	徐放性製剤およびその製造方法
DE10059412A1 (de) *	2000-11-30	2002-06-13	Gruenenthal Gmbh	Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie der Harninkontinenz
DE10146275A1 (de) *	2001-09-18	2003-04-24	Gruenenthal Gmbh	Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz

2002
- 2002-05-29 DE DE10224108A patent/DE10224108A1/de not_active Withdrawn
2003
- 2003-05-26 AU AU2003238397A patent/AU2003238397A1/en not_active Abandoned
- 2003-05-26 JP JP2004506791A patent/JP5459818B2/ja not_active Expired - Fee Related
- 2003-05-26 ES ES03732464T patent/ES2263976T3/es not_active Expired - Lifetime
- 2003-05-26 DK DK03732464T patent/DK1507519T3/da active
- 2003-05-26 AT AT03732464T patent/ATE326218T1/de not_active IP Right Cessation
- 2003-05-26 EP EP03732464A patent/EP1507519B1/de not_active Expired - Lifetime
- 2003-05-26 DE DE50303372T patent/DE50303372D1/de not_active Expired - Lifetime
- 2003-05-26 PT PT03732464T patent/PT1507519E/pt unknown
- 2003-05-26 CA CA2488220A patent/CA2488220C/en not_active Expired - Fee Related
- 2003-05-26 PL PL374186A patent/PL218397B1/pl unknown
- 2003-05-26 WO PCT/EP2003/005488 patent/WO2003099267A1/de not_active Ceased
- 2003-05-28 MY MYPI20031965A patent/MY134311A/en unknown
- 2003-05-29 PE PE2003000521A patent/PE20040529A1/es not_active Application Discontinuation
- 2003-05-29 AR ARP030101884A patent/AR039900A1/es unknown

Also Published As

Publication number	Publication date
JP2005534640A (ja)	2005-11-17
AR039900A1 (es)	2005-03-09
DE10224108A1 (de)	2004-01-29
DE50303372D1 (de)	2006-06-22
CA2488220A1 (en)	2003-12-04
MY134311A (en)	2007-12-31
AU2003238397A1 (en)	2003-12-12
PT1507519E (pt)	2006-08-31
DK1507519T3 (da)	2006-08-28
ATE326218T1 (de)	2006-06-15
EP1507519B1 (de)	2006-05-17
ES2263976T3 (es)	2006-12-16
PE20040529A1 (es)	2004-08-24
EP1507519A1 (de)	2005-02-23
CA2488220C (en)	2011-02-01
PL218397B1 (pl)	2014-11-28
JP5459818B2 (ja)	2014-04-02
WO2003099267A1 (de)	2003-12-04

Similar Documents

Publication	Publication Date	Title
PL372084A1 (pl)	2005-07-11	Związek pochodnej 8-azaprostaglandyny i środek zawierający ten związek jako składnik aktywny
PL374390A1 (pl)	2005-10-17	Grzybobójcze kompozycje substancji czynnych
TWI328576B (en)	2010-08-11	Diketohydrazine derivative compound, medicament containing same as active ingredient
HU0103988D0 (en)	2001-11-28	New compounds with pharmaceutical activity
AU2003252299A8 (en)	2004-02-16	Novel physiologically active substance
HU0103987D0 (en)	2001-11-28	New compounds with pharmaceutical activity
IL184288A0 (en)	2007-10-31	18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same
TWI345975B (en)	2011-08-01	Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
SI1608362T1 (sl)	2007-12-31	Stabiliziran farmacevtski izdelek z amorfno aktivno učinkovino
ZA200700397B (en)	2007-11-28	Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same
EP1731524A4 (en)	2009-05-20	PHENOLE DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE DERIVATIVE, AND ITS MEDICINAL USE
ZA200000171B (en)	2000-08-07	Analgesic with controlled active substance release.
HUP0400155A3 (en)	2007-05-02	N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
PL394600A1 (pl)	2011-07-18	Związek winyloazacykloalkanowy, sposób jego wytwarzania i jego zastosowanie oraz kompozycja farmaceutyczna
IL167187A (en)	2010-12-30	Composition comprising modafinil, said composition for use as a medicament and use of said composition for the preparation of medicament
PL372720A1 (pl)	2005-07-25	Leki zawierające czynne składniki obniżające poziom cholesterolu z opóźnionym w czasie uwalnianiem czynnego składnika
IL172666A0 (en)	2006-04-10	Compounds having anti-hcv activity and processes for the preparation thereof
EP1731609A4 (en)	2010-04-07	INHIBITOR OF THE EXPRESSION OF RAD51, MEDICAMENT CONTAINING THE INHIBITOR AS ACTIVE INGREDIENT AND USE THEREOF
ZA200602788B (en)	2008-01-30	Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2H-chromen-6-YL-derivatives and drugs containing said compounds
AU2003269871A1 (en)	2003-12-02	Radiosensitizer composition containing n-acetylphytosphingosine analogs and n,n-dimethyl-phytosphingosine analogs as the active ingredients
HUP0201810A3 (en)	2004-12-28	Sootepenseone and its derivatives, their preparation and use as medicament
SI1507519T1 (sl)	2006-10-31	Zdravilo, ki vsebuje 1-dimetilamino-3-(3-metoksi-fenil)-2-metil-pentan-3-ol, z zadrzevanim sproscanjem ucinkovine
AU2003238397A1 (en)	2003-12-12	Medicament with delayed release of the active substance, containing 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol
AP2029A (en)	2009-08-24	Microcapsules for the delayed, controlled release of perindopril
PL1781330T3 (pl)	2013-08-30	Kompozycje zawierające system aktywny względem naczyń włosowatych posiadający zdolność różnicowania związaną ze stosowaniem i ich zastosowanie